iXensor Co., Ltd. (TPEX:6734)

Market Cap	165.67M
Revenue (ttm)	16.91M
Net Income (ttm)	-57.15M
Shares Out	30.62M
EPS (ttm)	-2.61
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,102
Average Volume	30,866
Open	5.52
Previous Close	5.36
Day's Range	5.25 - 5.52
52-Week Range	3.86 - 19.00
Beta	0.14
RSI	44.90
Earnings Date	May 2, 2025

About iXensor

iXensor Co., Ltd. provides technology platform that turns smartphones into in vitro diagnostic devices through its smart color sensing technology for connected healthcare. The company’s PixoTest technology uses the lighting and image sensing module of the smartphone to detect the color change reaction on the immunoassay or colorimetric strip. It offers PixoTest Blood Glucose Monitoring System and PixoTest POCT System for chronic diseases management; Eveline Smart Fertility System and Eveline Care Telehealth Platform for women’s health managemen...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2012
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6734

Financial Performance

In 2023, iXensor's revenue was 20.89 million, a decrease of -80.15% compared to the previous year's 105.24 million. Losses were -63.19 million, 1191.7% more than in 2022.